tatton: updated results for patients with egfr-mutant positive nsclc
Published 5 years ago • 82 plays • Length 9:25Download video MP4
Download video MP3
Similar videos
-
2:30
tatton: osimertinib plus savolitinib for patients with egfr-mutant, met-amplified nsclc after pr...
-
1:56
what targeted therapies are used for people with the egfr mutation?
-
4:50
tatton: phase 1b trial of azd9291 for egfr-mutant lung cancer
-
2:46
gefitinib: targeted treatment for egfr mutation-positive lung cancer | glpbio
-
1:37
dr. konduri on treatment options for patients with egfr-mutant nsclc
-
5:03
understanding nsclc treatment when you have an egfr mutation
-
2:03:01
current and future management of non-small cell lung cancer with an egfr mutation
-
6:14
understanding biomarker testing in non-small cell lung cancer
-
6:43
sequential afatinib and osimertinib in egfr mutation-positive nsclc patients: updated results
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
0:55
osimertinib for egfr-mutant lung cancer
-
3:41
how do doctors treat lung cancer with egfr mutations?
-
1:55:29
2021 living with egfr-mutant lung cancer: a virtual forum for patients and caregivers
-
0:48
new standard of care for lung cancer patients with egfr mutations
-
3:50
what is an egfr mutation for lung cancer?
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
1:07
egfr mutation for lung cancer | egfr inhibitors | diagnosis & symptoms of egfr-positive lung cancer
-
2:18
egfr-mutant lung cancer: a patient's journey
-
1:04
molecular testing in egfr mutant driven nsclc
-
5:53
targeted therapy in non-small cell lung cancer
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
2:09
further: firmonertinib in nsclc with egfr pacc mutations